CCIA
OPRX icon

Campbell & Co Investment Adviser’s OptimizeRx OPRX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Buy
51,130
+18,270
+56% +$105K 0.02% 905
2026
Q1 		$206K Buy
32,860
+19,952
+155% +$185K 0.01% 960
2025
Q4 		$158K Buy
+12,908
New +$211K 0.01% 1078
2025
Q3 		– Sell
-48,397
Closed -$653K – 1314
2025
Q2 		$653K Sell
48,397
-262
-0.5% -$2.87K 0.04% 683
2025
Q1 		$421K Buy
48,659
+17,448
+56% +$107K 0.03% 750
2024
Q4 		$152K Sell
31,211
-13,618
-30% -$76.1K 0.01% 995
2024
Q3 		$346K Buy
44,829
+19,016
+74% +$169K 0.03% 847
2024
Q2 		$258K Buy
+25,813
New +$284K 0.02% 887
2023
Q2 		– Sell
-20,620
Closed -$302K – 1056
2023
Q1 		$302K Buy
+20,620
New +$345K 0.06% 601
2022
Q1 		– Sell
-7,100
Closed -$441K – 848
2021
Q4 		$441K Sell
7,100
-4,400
-38% -$333K 0.15% 234
2021
Q3 		$984K Buy
11,500
+5,600
+95% +$351K 0.32% 66
2021
Q2 		$365K Buy
+5,900
New +$300K 0.15% 254

Other funds holding OPRX

PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 46.14% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
AF
Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Campbell & Co Investment Adviser's OPRX Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its OptimizeRx (OPRX) stake by 56% in Q2 2026, buying an estimated $105K and bringing the position to 51,130 shares worth $292K. The position accounts for 0.02% of the portfolio, ranked #905.

Campbell & Co Investment Adviser first reported a position in OPRX in Q2 2021 and has held it in 12 quarters since. The position peaked at $984K in Q3 2021. 19 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Campbell & Co Investment Adviser held 51,130 shares of OptimizeRx worth $292K as of Q2 2026.
  • Campbell & Co Investment Adviser bought 18,270 OptimizeRx shares in Q2 2026, an estimated $105K.
  • OptimizeRx made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #905 holding.
  • Campbell & Co Investment Adviser first reported a position in OptimizeRx in Q2 2021 and has held it in 12 quarters since.
  • Campbell & Co Investment Adviser's OptimizeRx position peaked at $984K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.